{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,8]],"date-time":"2026-02-08T15:47:08Z","timestamp":1770565628065,"version":"3.49.0"},"reference-count":48,"publisher":"Oxford University Press (OUP)","issue":"7","license":[{"start":{"date-parts":[[2018,5,15]],"date-time":"2018-05-15T00:00:00Z","timestamp":1526342400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/about_us\/legal\/notices"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,7,1]]},"DOI":"10.1093\/jjco\/hyy069","type":"journal-article","created":{"date-parts":[[2018,4,30]],"date-time":"2018-04-30T03:16:49Z","timestamp":1525058209000},"page":"609-618","source":"Crossref","is-referenced-by-count":38,"title":["Clinicopathological and molecular differences between right-sided and left-sided colorectal cancer in Japanese patients"],"prefix":"10.1093","volume":"48","author":[{"given":"Soichiro","family":"Natsume","sequence":"first","affiliation":[{"name":"Tokyo Metropolitan Cancer and Infectious diseases Center Komagome Hospital, Tokyo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8454-1995","authenticated-orcid":false,"given":"Tatsuro","family":"Yamaguchi","sequence":"additional","affiliation":[{"name":"Tokyo Metropolitan Cancer and Infectious diseases Center Komagome Hospital, Tokyo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Misato","family":"Takao","sequence":"additional","affiliation":[{"name":"Tokyo Metropolitan Cancer and Infectious diseases Center Komagome Hospital, Tokyo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takeru","family":"Iijima","sequence":"additional","affiliation":[{"name":"Tokyo Metropolitan Cancer and Infectious diseases Center Komagome Hospital, Tokyo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rika","family":"Wakaume","sequence":"additional","affiliation":[{"name":"Tokyo Metropolitan Cancer and Infectious diseases Center Komagome Hospital, Tokyo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keiichi","family":"Takahashi","sequence":"additional","affiliation":[{"name":"Tokyo Metropolitan Cancer and Infectious diseases Center Komagome Hospital, Tokyo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Matsumoto","sequence":"additional","affiliation":[{"name":"Tokyo Metropolitan Cancer and Infectious diseases Center Komagome Hospital, Tokyo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daisuke","family":"Nakano","sequence":"additional","affiliation":[{"name":"Tokyo Metropolitan Cancer and Infectious diseases Center Komagome Hospital, Tokyo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shin-ichiro","family":"Horiguchi","sequence":"additional","affiliation":[{"name":"Tokyo Metropolitan Cancer and Infectious diseases Center Komagome Hospital, Tokyo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koichi","family":"Koizumi","sequence":"additional","affiliation":[{"name":"Tokyo Metropolitan Cancer and Infectious diseases Center Komagome Hospital, Tokyo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michiko","family":"Miyaki","sequence":"additional","affiliation":[{"name":"Tokyo Metropolitan Cancer and Infectious diseases Center Komagome Hospital, Tokyo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2018,5,15]]},"reference":[{"key":"key\n\t\t\t\t20180830005416_hyy069C1","doi-asserted-by":"crossref","first-page":"13","DOI":"10.2353\/jmoldx.2008.070082","article-title":"Molecular classification and correlates in colorectal cancer","volume":"10","author":"Ogino","year":"2008","journal-title":"J Mol Diagn"},{"key":"key\n\t\t\t\t20180830005416_hyy069C2","doi-asserted-by":"crossref","first-page":"6870","DOI":"10.1073\/pnas.95.12.6870","article-title":"Incidence and functional consequences of hMLH1 promoter hypermethylation in colorectal carcinoma","volume":"95","author":"Herman","year":"1988","journal-title":"Proc Natl Acad Sci U S A"},{"key":"key\n\t\t\t\t20180830005416_hyy069C3","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1056\/NEJM198809013190901","article-title":"Genetic alterations during colorectal-tumor development","volume":"319","author":"Vogelstein","year":"1998","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20180830005416_hyy069C4","first-page":"7166","article-title":"Genetic changes and histopathological types in colorectal tumors from patients with familial adenomatous polyposis","volume":"50","author":"Miyaki","year":"1990","journal-title":"Cancer Res"},{"key":"key\n\t\t\t\t20180830005416_hyy069C5","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1038\/sj.onc.1201986","article-title":"Chromosome number and structure both are markedly stable in RER colorectal cancers and are not destabilized by mutation of p53","volume":"17","author":"Eshleman","year":"1998","journal-title":"Oncogene"},{"key":"key\n\t\t\t\t20180830005416_hyy069C6","doi-asserted-by":"crossref","first-page":"8681","DOI":"10.1073\/pnas.96.15.8681","article-title":"CpG island methylator phenotype in colorectal cancer","volume":"96","author":"Toyota","year":"1999","journal-title":"Proc Natl Acad Sci U S A"},{"key":"key\n\t\t\t\t20180830005416_hyy069C7","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1136\/gut.2003.037671","article-title":"BRAF mutation is associated with DNA methylation in serrated polyps and cancers of the colorectum","volume":"53","author":"Kambara","year":"2004","journal-title":"Gut"},{"key":"key\n\t\t\t\t20180830005416_hyy069C8","doi-asserted-by":"crossref","first-page":"779","DOI":"10.7326\/0003-4819-113-10-779","article-title":"Colorectal cancer: evidence for distinct genetic categories based on proximal or distal tumor location","volume":"113","author":"Bufill","year":"1990","journal-title":"Ann Intern Med"},{"key":"key\n\t\t\t\t20180830005416_hyy069C9","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1002\/ijc.10635","article-title":"Are there two sides to colorectal cancer?","volume":"101","author":"Iacopetta","year":"2002","journal-title":"Int J Cancer"},{"key":"key\n\t\t\t\t20180830005416_hyy069C10","first-page":"5248","article-title":"A National Cancer Institute Workshop on Microsatellite Instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer","volume":"58","author":"Boland","year":"1998","journal-title":"Cancer Res"},{"key":"key\n\t\t\t\t20180830005416_hyy069C11","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1038\/25292","article-title":"Genetic instabilities in human cancers","volume":"396","author":"Lengauer","year":"1998","journal-title":"Nature"},{"key":"key\n\t\t\t\t20180830005416_hyy069C12","doi-asserted-by":"crossref","first-page":"4591","DOI":"10.1200\/JCO.2009.22.8858","article-title":"Prognostic significance and molecular associations of 18q loss of heterozygosity: a cohort study of microsatellite stable colorectal cancers","volume":"27","author":"Ogino","year":"2009","journal-title":"J Clin Oncol"},{"key":"key\n\t\t\t\t20180830005416_hyy069C13","doi-asserted-by":"crossref","first-page":"209","DOI":"10.2353\/jmoldx.2006.050135","article-title":"Precision and performance characteristics of bisulfite conversion and real-time PCR (MethyLight) for quantitative DNA methylation analysis","volume":"8","author":"Ogino","year":"2006","journal-title":"J Mol Diagn"},{"key":"key\n\t\t\t\t20180830005416_hyy069C14","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1136\/gut.2005.082933","article-title":"CpG island methylator phenotype (CIMP) of colorectal cancer is best characterised by quantitative DNA methylation analysis and prospective cohort studies","volume":"55","author":"Ogino","year":"2006","journal-title":"Gut"},{"key":"key\n\t\t\t\t20180830005416_hyy069C15","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1038\/bmt.2012.244","article-title":"Investigation of the freely available easy-to-use software \u2018EZR\u2019 for medical statistics","volume":"48","author":"Kanda","year":"2013","journal-title":"Bone Marrow Transplant"},{"key":"key\n\t\t\t\t20180830005416_hyy069C16","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1111\/j.1365-2559.2006.02549.x","article-title":"Classification of colorectal cancer based on correlation of clinical, morphological and molecular features","volume":"50","author":"Jass","year":"2007","journal-title":"Histopathology"},{"key":"key\n\t\t\t\t20180830005416_hyy069C17","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1053\/j.gastro.2014.09.038","article-title":"Association between molecular subtypes of colorectal cancer and patient survival","volume":"148","author":"Phipps","year":"2015","journal-title":"Gastroenterology"},{"key":"key\n\t\t\t\t20180830005416_hyy069C18","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1053\/j.gastro.2014.09.041","article-title":"Molecular markers identify subtypes of stage III colon cancer associated with patient outcomes","volume":"148","author":"Sinicrope","year":"2015","journal-title":"Gastroenterology"},{"key":"key\n\t\t\t\t20180830005416_hyy069C19","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1038\/nm.3967","article-title":"The consensus molecular subtypes of colorectal cancer","volume":"21","author":"Guinney","year":"2015","journal-title":"Nat Med"},{"key":"key\n\t\t\t\t20180830005416_hyy069C20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10147-011-0315-2","article-title":"Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2010 for the treatment of colorectal cancer","volume":"17","author":"Watanabe","year":"2012","journal-title":"Int J Clin Oncol"},{"key":"key\n\t\t\t\t20180830005416_hyy069C21","doi-asserted-by":"crossref","first-page":"104","DOI":"10.3322\/caac.21220","article-title":"Colorectal cancer statistics, 2014","volume":"64","author":"Siegel","year":"2014","journal-title":"CA Cancer J Clin"},{"key":"key\n\t\t\t\t20180830005416_hyy069C22","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/BF02234301","article-title":"Predictors of proximal vs. distal colorectal cancers","volume":"44","author":"Gonzalez","year":"2001","journal-title":"Dis Colon Rectum"},{"key":"key\n\t\t\t\t20180830005416_hyy069C23","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1007\/s00464-001-8304-6","article-title":"Advanced proximal colon cancer","volume":"16","author":"Gannon","year":"2002","journal-title":"Surg Endosc"},{"key":"key\n\t\t\t\t20180830005416_hyy069C24","first-page":"A4444","article-title":"Possible better long-term survival in left versus right-sided colon cancer \u2013 a systematic review","volume":"59","author":"Hansen","year":"2012","journal-title":"Dan Med J"},{"key":"key\n\t\t\t\t20180830005416_hyy069C25","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1053\/gast.2002.35392","article-title":"Emerging concepts in colorectal neoplasia","volume":"123","author":"Jass","year":"2002","journal-title":"Gastroenterology"},{"key":"key\n\t\t\t\t20180830005416_hyy069C26","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1136\/gutjnl-2011-300865","article-title":"Assessment of colorectal cancer molecular features along bowel subsites challenges the conception of distinct dichotomy of proximal versus distal colorectum","volume":"61","author":"Yamauchi","year":"2012","journal-title":"Gut"},{"key":"key\n\t\t\t\t20180830005416_hyy069C27","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1136\/gut.2008.155473","article-title":"CpG island methylator phenotype, microsatellite instability, BRAF mutation and clinical outcome in colon cancer","volume":"58","author":"Ogino","year":"2009","journal-title":"Gut"},{"key":"key\n\t\t\t\t20180830005416_hyy069C28","doi-asserted-by":"crossref","first-page":"6063","DOI":"10.1158\/0008-5472.CAN-05-0404","article-title":"Poor survival associated with the BRAF V600E mutation in microsatellite-stable colon cancers","volume":"65","author":"Samowitz","year":"2005","journal-title":"Cancer Res"},{"key":"key\n\t\t\t\t20180830005416_hyy069C29","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1200\/JCO.2010.30.1366","article-title":"Value of mismatch repair, KRAS, and BRAF mutations in predicting recurrence and benefits from chemotherapy in colorectal cancer","volume":"29","author":"Hutchins","year":"2011","journal-title":"J Clin Oncol"},{"key":"key\n\t\t\t\t20180830005416_hyy069C30","doi-asserted-by":"crossref","first-page":"2953","DOI":"10.1111\/j.1572-0241.2000.02327.x","article-title":"Impact of KRAS and TP53 mutations on survival in patients with left- and right-sided Dukes\u2019 C colon cancer","volume":"95","author":"Bleeker","year":"2000","journal-title":"Am J Gastroenterol"},{"key":"key\n\t\t\t\t20180830005416_hyy069C31","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1007\/s10350-004-0628-6","article-title":"Association between recurrence of sporadic colorectal cancer, high level of microsatellite instability, and loss of heterozygosity at chromosome 18q","volume":"47","author":"Sarli","year":"2004","journal-title":"Dis Colon Rectum"},{"key":"key\n\t\t\t\t20180830005416_hyy069C32","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1002\/(SICI)1097-0215(19980821)79:4<390::AID-IJC14>3.0.CO;2-9","article-title":"Chromosome 18q allelic loss and prognosis in stage II and III colon cancer","volume":"79","author":"Lanza","year":"1998","journal-title":"Int J Cancer"},{"key":"key\n\t\t\t\t20180830005416_hyy069C33","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1097\/00001622-200101000-00013","article-title":"Different mechanisms in the tumorigenesis of proximal and distal colon cancers","volume":"13","author":"Lindblom","year":"2001","journal-title":"Curr Opin Oncol"},{"key":"key\n\t\t\t\t20180830005416_hyy069C34","doi-asserted-by":"crossref","first-page":"4623","DOI":"10.1002\/cncr.26086","article-title":"Impact of BRAF mutation and microsatellite instability on the pattern of metastatic spread and prognosis in metastatic colorectal cancer","volume":"117","author":"Tran","year":"2011","journal-title":"Cancer"},{"key":"key\n\t\t\t\t20180830005416_hyy069C35","doi-asserted-by":"crossref","first-page":"dju427","DOI":"10.1093\/jnci\/dju427","article-title":"Primary tumor location as a prognostic factor in metastatic colorectal cancer","volume":"107","author":"Loupakis","year":"2015","journal-title":"J Natl Cancer Inst"},{"key":"key\n\t\t\t\t20180830005416_hyy069C36","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/s00384-006-0093-x","article-title":"Distinct molecular patterns based on proximal and distal sporadic colorectal cancer: arguments for different mechanisms in the tumorigenesis","volume":"22","author":"Azzoni","year":"2007","journal-title":"Int J Colorectal Dis"},{"key":"key\n\t\t\t\t20180830005416_hyy069C37","doi-asserted-by":"crossref","first-page":"2048","DOI":"10.1093\/annonc\/mdt076","article-title":"A novel classification of colorectal tumors based on microsatellite instability, the CpG island methylator phenotype and chromosomal instability: implications for prognosis","volume":"24","author":"Simons","year":"2013","journal-title":"Ann Oncol"},{"key":"key\n\t\t\t\t20180830005416_hyy069C38","first-page":"1691","article-title":"KRAS, BRAF and PIK3CA mutations in human colorectal cancer: relationship with metastatic colorectal cancer","volume":"25","author":"Li","year":"2011","journal-title":"Oncol Rep"},{"key":"key\n\t\t\t\t20180830005416_hyy069C39","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1007\/s00384-011-1229-1","article-title":"Mutations in BRAF correlate with poor survival of colorectal cancers in Chinese population","volume":"26","author":"Liou","year":"2011","journal-title":"Int J Colorectal Dis"},{"key":"key\n\t\t\t\t20180830005416_hyy069C40","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1186\/1476-4598-13-168","article-title":"A very low incidence of BRAF mutations in Middle Eastern colorectal carcinoma","volume":"13","author":"Siraj","year":"2014","journal-title":"Mol Cancer"},{"key":"key\n\t\t\t\t20180830005416_hyy069C41","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1038\/bjc.2013.430","article-title":"Prognostic implication of the CpG island methylator phenotype in colorectal cancers depends on tumour location","volume":"109","author":"Bae","year":"2013","journal-title":"Br J Cancer"},{"key":"key\n\t\t\t\t20180830005416_hyy069C42","doi-asserted-by":"crossref","first-page":"e2260","DOI":"10.1097\/MD.0000000000002260","article-title":"Low-level microsatellite instability as a potential prognostic factor in sporadic colorectal cancer","volume":"94","author":"Lee","year":"2015","journal-title":"Medicine (Baltimore)"},{"key":"key\n\t\t\t\t20180830005416_hyy069C43","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/1423-0127-18-36","article-title":"Molecular profile and copy number analysis of sporadic colorectal cancer in Taiwan","volume":"18","author":"Lin","year":"2011","journal-title":"J Biomed Sci"},{"key":"key\n\t\t\t\t20180830005416_hyy069C44","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1631\/jzus.B1000198","article-title":"Comparative features of colorectal and gastric cancers with microsatellite instability in Chinese patients","volume":"11","author":"Huang","year":"2010","journal-title":"J Zhejiang Univ Sci B"},{"key":"key\n\t\t\t\t20180830005416_hyy069C45","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1093\/annonc\/mdu232","article-title":"S-1 as adjuvant chemotherapy for stage III colon cancer: a randomized phase III study (ACTS-CC trial)","volume":"25","author":"Yoshida","year":"2014","journal-title":"Ann Oncol"},{"key":"key\n\t\t\t\t20180830005416_hyy069C46","doi-asserted-by":"crossref","first-page":"3733","DOI":"10.1200\/JCO.2015.60.9107","article-title":"Capecitabine plus oxaliplatin compared with fluorouracil\/folinic acid as adjuvant therapy for Stage III colon cancer: final results of the NO16968 Randomized Controlled Phase III Trial","volume":"33","author":"Schmoll","year":"2015","journal-title":"J Clin Oncol"},{"key":"key\n\t\t\t\t20180830005416_hyy069C47","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1016\/S1470-2045(13)70490-X","article-title":"Leucovorin, fluorouracil, and oxaliplatin plus bevacizumab versus S-1 and oxaliplatin plus bevacizumab in patients with metastatic colorectal cancer (SOFT): an open-label, non-inferiority, randomised phase 3 trial","volume":"14","author":"Yamada","year":"2013","journal-title":"Lancet Oncol"},{"key":"key\n\t\t\t\t20180830005416_hyy069C48","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1038\/bjc.2011.201","article-title":"XELOX vs FOLFOX-4 as first-line therapy for metastatic colorectal cancer: NO16966 updated results","volume":"105","author":"Cassidy","year":"2011","journal-title":"Br J Cancer"}],"container-title":["Japanese Journal of Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jjco\/article-pdf\/48\/7\/609\/25536218\/hyy069.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,17]],"date-time":"2019-10-17T02:31:04Z","timestamp":1571279464000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jjco\/article\/48\/7\/609\/4996059"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5,15]]},"references-count":48,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2018,5,15]]},"published-print":{"date-parts":[[2018,7,1]]}},"URL":"https:\/\/doi.org\/10.1093\/jjco\/hyy069","relation":{},"ISSN":["1465-3621"],"issn-type":[{"value":"1465-3621","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2018,7]]},"published":{"date-parts":[[2018,5,15]]}}}